Insider Trading: Verenium Corp (VRNM.O)
VRNM.O on Consolidated Issue listed on NASDAQ Global Market
2.21USD
24 May 2013
2.21USD
24 May 2013
Price Change (% chg)
$-0.02 (-0.90%)
$-0.02 (-0.90%)
Prev Close
$2.23
$2.23
Open
$2.15
$2.15
Day's High
$2.21
$2.21
Day's Low
$2.15
$2.15
Volume
2,700
2,700
Avg. Vol
15,789
15,789
52-wk High
$4.69
$4.69
52-wk Low
$2.05
$2.05
| BLACK JEFFREY G | Options Exercised: 0 | ||
| Trade Date: | Monday, 15 Aug 2011 | Price: | 2.05 |
| Title: | Chief Financial Officer | Shares Held: | 6,125 |
| Type Traded: | Indirect | Net Change in Shares This Filing: | 1,875 |
Institutional Holders
| % Shares Owned: | 38.32% |
| # of Holders: | 37 |
| Total Shares Held: | 4,899,284 |
| 3 Mo. Net Change: | 100,462 |
| # New Positions: | 1 |
| # Closed Positions: | 2 |
| # Increased Positions: | 7 |
| # Reduced Positions: | 6 |
| # Net Buyers: | 1 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
James Cavanaugh |
75 | 1998 | Independent Chairman of the Board |
James Levine |
41 | 2011 | President, Chief Executive Officer, Director |
Jeffrey Black |
43 | 2011 | Chief Financial Officer, Senior Vice President |
Janet Roemer |
56 | 2010 | Chief Operating Officer, Executive Vice President - Specialty Enzymes Business Unit |
Alexander Fitzpatrick |
45 | 2010 | Senior Vice President, General Counsel, Secretary |
Holger Liepmann |
61 | 2013 | Director |
John Dee |
2008 | Independent Director | |
Peter Johnson |
66 | 1999 | Independent Director |
Fernand Kaufmann |
69 | 2004 | Independent Director |
Joshua Ruch |
2007 | Independent Director | |
Cheryl Wenzinger |
63 | 2004 | Independent Director |

